Press Releases April 15, 2026 08:00 PM

iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026

iRhythm Holdings Announces Q1 2026 Earnings Release Date and Conference Call

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
IRTC

iRhythm Holdings, Inc., a digital healthcare company specializing in wearable biosensors and data analytics for disease detection and prevention, announced that it will release its first quarter 2026 financial results after market close on April 30, 2026. The company will host a conference call for investors the same day to discuss the results.

iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
IRTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Q1 2026 financial results to be released on April 30, 2026 after market close.
  • Conference call scheduled for investors on April 30, 2026 to discuss earnings.
  • Company focus on digital healthcare solutions using wearable biosensors and data analytics impacts the healthcare and technology sectors.

SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
investors@irhythmtech.com

Media Contact
Kassandra Perry
mediarelations@irhythmtech.com


Risks

  • Financial results may not meet market expectations, potentially affecting stock price and investor confidence.
  • Regulatory and market risks inherent in the digital health and wearable technology sectors.
  • Dependence on continued adoption and reimbursement of digital health solutions in the healthcare market.

More from Press Releases

Decent Holding Inc. Forms Partnership with Taihao Robotics to Launch Real-World Robotics Training Network in China Jun 9, 2026 AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules Jun 9, 2026 Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA) Jun 9, 2026 AppFolio Connects Realm-X to Anthropic’s Claude, Setting a New Standard for Real Estate Performance Management Jun 9, 2026 TransAlta Announces Closing of $350 Million Bought Deal Offering of Common Shares Jun 9, 2026